Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers-Reference-Cited by-同舟云学术

Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers

Published:2015-12-28 Issue:6 Volume:118 Page:474-479
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Cojutti Piergiorgio¹²,Candoni Anna³,Forghieri Fabio⁴,Isola Miriam⁵,Zannier Maria Elena³,Bigliardi Sara⁴,Luppi Mario⁴,Fanin Renato³,Pea Federico¹²

Affiliation:

1. Institute of Clinical Pharmacology; University Teaching Hospital of Udine; Udine Italy

2. Department of Experimental and Clinical Medical Sciences; University of Udine; Udine Italy

3. Division of Haematology; University Teaching Hospital of Udine; Udine Italy

4. Department of Medical and Surgical Sciences; Section of Haematology; University of Modena and Reggio Emilia; University Teaching Hospital of Modena; Modena Italy

5. Department of Medical and Biological Sciences; Section of Statistics; University of Udine; Udine Italy

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12530/fullpdf

Reference33 articles.

1. Patients at high risk of invasive fungal infections: when and how to treat;Ruping;Drugs,2008

2. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America;Walsh;Clin Infect Dis,2008

3. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haematopoietic stem cell transplantation, 2014;Blyth;Intern Med J,2014

4. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update;Maertens;Bone Marrow Transplant,2011

5. Pharmacokinetic/pharmacodynamic profile of voriconazole;Theuretzbacher;Clin Pharmacokinet,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-08-23

2. The Effect of Rifapentine and Rifampicin on Serum Voriconazole Levels Persist for 5 Days and 7 Days or More After Discontinuation in Tuberculosis Patients with Chronic Pulmonary Aspergillosis;Infection and Drug Resistance;2024-07

3. Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review;Molecules;2023-08-14

4. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients;Journal of Fungi;2023-05-30

5. Why are the Therapeutic Drug Monitoring Results of Voriconazole Inconsistent with CYP2C19 Genetic Testing?;Journal of the College of Physicians and Surgeons Pakistan;2023-05-01